Impact of Neutropenia on the Effectiveness of Artemisinin-Based Combination Therapy in Pregnant Women in Mali - Report - MDSpire

Impact of Neutropenia on the Effectiveness of Artemisinin-Based Combination Therapy in Pregnant Women in Mali

  • By

  • Moussa Djimde

  • Charles Arama

  • Hamadoun Diakité

  • Mohamed Keita

  • Bouréma Koné

  • Bréhima Tembely

  • Mamadou D. Samaké

  • Balla Bagayoko

  • Mohamed B. Traoré

  • Japhet Kabalu Tshiongo

  • Noluthando Ntlapo

  • Alassane Dicko

  • Michel Vaillant

  • Petra F. Mens

  • Henk D. F. H. Schallig

  • Kassoum Kayentao

  • January 27, 2026

  • 0 min

Share

Clinical Report: Impact of Neutropenia on ACT Effectiveness in Pregnant Women

Overview

This study investigates the effects of neutropenia on the efficacy of artemisinin-based combination therapies (ACTs) in pregnant women with malaria in Mali. Findings suggest that neutropenia may negatively impact treatment outcomes, highlighting the need for further research in this area.

Background

Malaria during pregnancy significantly increases health risks for mothers and infants, including higher rates of anemia and low birth weight. In Mali, where malaria is a leading cause of morbidity and mortality, understanding factors that affect treatment efficacy is crucial for improving maternal and infant health outcomes. Neutrophils play a vital role in the immune response, yet their impact on the effectiveness of ACTs in pregnant women remains underexplored.

Data Highlights

No numerical data available in the provided source material.

Key Findings

  • Neutropenia in pregnant women may reduce the efficacy of ACTs against malaria.
  • The study assessed the in vivo efficacy of three ACTs: artemether-lumefantrine, dihydroartemisinin-piperaquine, and pyronaridine-artesunate.
  • Neutrophils are critical for the immune response, yet their role in malaria infection during pregnancy is not well understood.
  • Pregnant women with malaria are particularly vulnerable to complications such as anemia and low birth weight.
  • Malaria remains a significant public health issue in Mali, with high maternal mortality rates linked to the disease.

Clinical Implications

Healthcare providers should consider the neutrophil status of pregnant women when evaluating the efficacy of ACTs for malaria treatment. Enhanced monitoring and potential adjustments in treatment strategies may be necessary for neutropenic patients to improve outcomes.

Conclusion

The findings underscore the importance of understanding the role of neutrophils in malaria treatment during pregnancy. Further research is needed to clarify the relationship between neutropenia and ACT efficacy.

References

  1. World Health Organization, World Malaria Report 2023 -- Malaria in Pregnancy
  2. Drugs - Real World Outcomes, 2018 -- Assessment of Medication Safety in Pregnant Women
  3. Open Forum Infectious Diseases, 2021 -- Impact of Antimalarial Drug Selection for Pregnancy
  4. The Journal of Infectious Diseases, 2022 -- Artemether-Lumefantrine Treatment and Multidrug Resistance
  5. WHO guidelines for malaria, 2025 -- Updated Malaria Treatment Guidelines
  6. American Journal of Epidemiology — Assessing the Impact of Anemia Interventions on Reducing Adverse Birth Outcomes Disparities in HIV-Positive Individuals
  7. WHO Malaria Guidelines

Original Source(s)

Related Content